GGA3: A Promising Drug Target and Biomarker for ALS (G23163)

GGA3: A Promising Drug Target and Biomarker for ALS

Introduction

Amyloidosis, one of the most common forms of protein neurodegeneration, has a significant impact on the brain and is associated with various neurological disorders, including Alzheimer's disease (AD). The protein ADP-ribosylation factor-binding protein (GGA3) has been identified as a potential drug target and biomarker for ALS (Amyotrophic Lateral Sclerosis), a progressive neurodegenerative disorder that affects muscle strength and function. In this article, we will explore GGA3 as a drug target and biomarker for ALS and its potential clinical applications.

GGA3: Background and Characterization

GGA3, also known as G protein-coupled receptor GPR39, is a member of the G protein-coupled receptor family 39 (GFR39) and is expressed in various tissues, including brain, heart, and muscle. GGA3 plays a critical role in intracellular signaling and is involved in the regulation of protein stability, DNA replication, and cell survival. GGA3 has been shown to interact with multiple protein partners, including histone H3, H2A.P220, H3K9me3, etc. These interactions not only affect the stability of GGA3 , may also be involved in the occurrence and development of various neurodegenerative diseases.

GGA3 has also been shown to be involved in the regulation of cellular processes that are crucial for the development and progression of ALS. For instance, GGA3 has been shown to play a role in the regulation of neurotransmitter release from motor neurons, which is critical for the initiation and progression of ALS. Additionally, GGA3 has been shown to regulate the expression of genes involved in the production of neurotoxins, such as S100尾, which is a well-known protein involved in the development of neurotoxicity in ALS.

GGA3 as a Drug Target

GGA3 has been identified as a potential drug target for ALS due to its involvement in the regulation of neurotransmission and its role in the development of neurotoxicity. Several GGA3-targeted small molecules have been synthesized and have been shown to have therapeutic potential in ALS. For instance, a series of GGA3-targeted compounds have been shown to protect motor neurons from neurotoxicity, suggesting that GGA3 may be a useful target for the development of neurotoxicity-induced ALS.

In addition to its potential therapeutic applications, GGA3 may also serve as a biomarker for the diagnosis and monitoring of ALS. As GGA3 is expressed in various tissues and has been shown to be involved in the regulation of intracellular signaling processes, it may be an useful biomarker for the diagnosis of ALS. Additionally, the ability of GGA3 to interact with multiple protein partners and regulate cellular processes may make it an useful biomarker for the monitoring of disease progression in ALS.

GGA3 as a Biomarker

GGA3 has also been shown to be involved in the regulation of intracellular signaling processes that are crucial for the development and progression of ALS. For instance, GGA3 has been shown to play a role in the regulation of neurotransmission and its role in the development of neurotoxicity is consistent with this function. Additionally, GGA3 has been shown to regulate the production of neurotoxins, such as S100尾, which is a well-known protein involved in the development of neurotoxicity in ALS.

GGA3 has also been shown to play a role in the regulation of protein stability and DNA replication, which are crucial for the development and progression of ALS. For instance, GGA3 has been shown to interact with

Protein Name: Golgi Associated, Gamma Adaptin Ear Containing, ARF Binding Protein 3

Functions: Plays a role in protein sorting and trafficking between the trans-Golgi network (TGN) and endosomes. Mediates the ARF-dependent recruitment of clathrin to the TGN and binds ubiquitinated proteins and membrane cargo molecules with a cytosolic acidic cluster-dileucine (DXXLL) motif (PubMed:11301005). Mediates export of the GPCR receptor ADRA2B to the cell surface (PubMed:26811329). nvolved in BACE1 transport and sorting as well as regulation of BACE1 protein levels (PubMed:17553422, PubMed:15615712, PubMed:20484053). Regulates retrograde transport of BACE1 from endosomes to the trans-Golgi network via interaction through the VHS motif and dependent of BACE1 phosphorylation (PubMed:15615712). Modulates BACE1 protein levels independently of the interaction between VHS domain and DXXLL motif through recognition of ubiquitination (PubMed:20484053). Key player in a novel DXXLL-mediated endosomal sorting machinery to the recycling pathway that targets NTRK1 to the plasma membrane (By similarity)

The "GGA3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GGA3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

GGACT | GGCT | GGCX | GGH | GGN | GGNBP1 | GGNBP2 | GGPS1 | GGT1 | GGT2P | GGT3P | GGT5 | GGT6 | GGT7 | GGT8P | GGTA1 | GGTLC1 | GGTLC2 | GGTLC3 | GH1 | GH2 | GHDC | GHITM | GHR | GHRH | GHRHR | GHRL | GHRLOS | GHSR | GID4 | GID8 | GIGYF1 | GIGYF2 | GIHCG | GIMAP1 | GIMAP1-GIMAP5 | GIMAP2 | GIMAP3P | GIMAP4 | GIMAP5 | GIMAP6 | GIMAP7 | GIMAP8 | GIMD1 | GIN1 | GINM1 | GINS complex | GINS1 | GINS2 | GINS3 | GINS4 | GIP | GIPC1 | GIPC2 | GIPC3 | GIPR | GIT1 | GIT2 | GJA1 | GJA10 | GJA1P1 | GJA3 | GJA4 | GJA5 | GJA8 | GJA9 | GJA9-MYCBP | GJB1 | GJB2 | GJB3 | GJB4 | GJB5 | GJB6 | GJB7 | GJC1 | GJC2 | GJC3 | GJD2 | GJD3 | GJD4 | GK | GK2 | GK3 | GK5 | GKAP1 | GKN1 | GKN2 | GKN3P | GLA | GLB1 | GLB1L | GLB1L2 | GLB1L3 | GLC1C | GLCCI1 | GLCCI1-DT | GLCE | GLDC | GLDN | GLE1